Axel Buob1, H Winter, M Kindermann, G Becker, J C Möller, W H Oertel, M Böhm. 1. Klinik für Innere Medizin III Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, 66421 Homburg/Saar, Germany. axel.buob@uks.eu
Abstract
BACKGROUND: Autonomic cardiovascular dysfunction is common in Parkinson's disease (PD). Imaging studies suggest loss of cardiac sympathetic nerves even in the absence of clinical signs of autonomic dysfunction. Aim of the study was to investigate the functional significance of autonomic cardiovascular denervation at early stages of PD. METHODS: Seven PD patients (Hoehn and Yahr class 1 or 1.5) without clinical signs of autonomic dysfunction and seven age-matched healthy control subjects were studied. To evaluate the pre- and post-synaptic components of sympathetic innervation, dose-response curves of isoproterenol (no neuronal uptake) and epinephrine (neuronal uptake) on heart rate, contractility, cardiac output and systemic vascular resistance were determined echocardiographically. Additionally, measurements of baroreflex sensitivity and 24-h heart rate variability were done. RESULTS: The chronotropic and inotropic responses during stimulation with isoproterenol and epinephrine were similar in PD patients and control subjects. Assessment of baroreflex sensitivity yielded no difference. Of the parameters of 24-h heart rate variability, only measures of high-frequency heart rate variation that more purely reflect parasympathetic activity were significantly depressed in PD patients as compared with control subjects. CONCLUSIONS: The results of our study using direct determination of catecholamine-mediated chronotropic and contractile responses provide evidence against a functionally relevant sympathetic dysfunction. Possibly, sympathetic denervation is incomplete and the remaining fibers are sufficient for the maintenance of autonomic control. In contrast, the depression of several parameters of heart rate variability supports a significant change of parasympathetic activity at an early stage of PD with subclinical autonomic failure.
BACKGROUND: Autonomic cardiovascular dysfunction is common in Parkinson's disease (PD). Imaging studies suggest loss of cardiac sympathetic nerves even in the absence of clinical signs of autonomic dysfunction. Aim of the study was to investigate the functional significance of autonomic cardiovascular denervation at early stages of PD. METHODS: Seven PDpatients (Hoehn and Yahr class 1 or 1.5) without clinical signs of autonomic dysfunction and seven age-matched healthy control subjects were studied. To evaluate the pre- and post-synaptic components of sympathetic innervation, dose-response curves of isoproterenol (no neuronal uptake) and epinephrine (neuronal uptake) on heart rate, contractility, cardiac output and systemic vascular resistance were determined echocardiographically. Additionally, measurements of baroreflex sensitivity and 24-h heart rate variability were done. RESULTS: The chronotropic and inotropic responses during stimulation with isoproterenol and epinephrine were similar in PDpatients and control subjects. Assessment of baroreflex sensitivity yielded no difference. Of the parameters of 24-h heart rate variability, only measures of high-frequency heart rate variation that more purely reflect parasympathetic activity were significantly depressed in PDpatients as compared with control subjects. CONCLUSIONS: The results of our study using direct determination of catecholamine-mediated chronotropic and contractile responses provide evidence against a functionally relevant sympathetic dysfunction. Possibly, sympathetic denervation is incomplete and the remaining fibers are sufficient for the maintenance of autonomic control. In contrast, the depression of several parameters of heart rate variability supports a significant change of parasympathetic activity at an early stage of PD with subclinical autonomic failure.
Authors: M Kallio; T Haapaniemi; J Turkka; K Suominen; U Tolonen; K Sotaniemi; V P Heikkilä; V Myllylä Journal: Eur J Neurol Date: 2000-11 Impact factor: 6.089
Authors: A Druschky; M J Hilz; G Platsch; M Radespiel-Tröger; K Druschky; T Kuwert; B Neundörfer Journal: J Neurol Sci Date: 2000-04-01 Impact factor: 3.181
Authors: Heiko Braak; Magdalena Sastre; Jürgen R E Bohl; Rob A I de Vos; Kelly Del Tredici Journal: Acta Neuropathol Date: 2007-02-09 Impact factor: 17.088
Authors: Jan Giso Peter; Martin Glos; Alexander Blau; Thomas Penzel; Gert Baumann; Ingo Fietze Journal: Clin Res Cardiol Date: 2010-11-24 Impact factor: 5.460
Authors: Kathleen J Griffioen; Sarah M Rothman; Bruce Ladenheim; Ruiqian Wan; Neil Vranis; Emmette Hutchison; Eitan Okun; Jean Lud Cadet; Mark P Mattson Journal: Neurobiol Aging Date: 2012-08-09 Impact factor: 4.673
Authors: Eva S Kehmeier; Wolfgang Lepper; Martina Kropp; Christian Heiss; Ulrike Hendgen-Cotta; Jan Balzer; Mirja Neizel; Christian Meyer; Marc W Merx; Pablo E Verde; Christian Ohmann; Gerd Heusch; Malte Kelm; Tienush Rassaf Journal: Clin Res Cardiol Date: 2012-05-06 Impact factor: 5.460
Authors: Sheila M Fleming; Maria C Jordan; Caitlin K Mulligan; Eliezer Masliah; John G Holden; Ronald W Millard; Marie-Françoise Chesselet; Kenneth P Roos Journal: Front Neurol Date: 2013-07-23 Impact factor: 4.003
Authors: Claudia Carricarte Naranjo; Connie Marras; Naomi P Visanji; David J Cornforth; Lazaro Sanchez-Rodriguez; Birgitt Schüle; Samuel M Goldman; Mario Estévez; Phyllis K Stein; Anthony E Lang; Herbert F Jelinek; Andrés Machado Journal: Clin Auton Res Date: 2021-07-12 Impact factor: 4.435
Authors: Jeong Hun Yang; Sang Ho Choi; Mi Hyun Lee; Seong Min Oh; Jae-Won Choi; Jee Eun Park; Kwang Suk Park; Yu Jin Lee Journal: J Clin Sleep Med Date: 2021-03-01 Impact factor: 4.062